Stratec SE

Price Chart

Risk-Adjusted Performance

Also Listed On

Stratec SE (SBS) Price Performance

Stratec SE (SBS) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at EUR19.96, up 0.60% from the previous close.

Over the past year, SBS has traded between a low of EUR16.86 and a high of EUR32.00. The stock has lost 16.8% over this period. It is currently 37.6% below its 52-week high.

Stratec SE has a market capitalization of $241.17M, with a price-to-earnings ratio of 15.62 and a dividend yield of 3.25%.

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.